Table 3.
Associations between plasma ET-1 levels and circulating angiogenic cells.
| Association parameters between CACs & ET-1 | |||
|---|---|---|---|
| CACs | β | p-value | 95% Confidence Interval |
| CD34+/CD31+/CD45− | 0.148 | 0.511 | −0.303, 0.599 |
| CD34+/CD31+/CD45+ | 0.458 | 0.068† | −0.035, 0.951 |
| CD34+/CD31+/CD45−/CD133+ | 0.010 | 0.936 | −0.232, 0.251 |
| CD34+/CD31+/CD45+/CD133+ | 0.402 | 0.066† | −0.029, 0.833 |
| CD31+/CD133+ | −0.022 | 0.854 | −0.266, 0.221 |
| CD34+/CD31+ | 0.281 | 0.211 | −0.165, 0.726 |
| CD34+/CD31+/CD45−/CD133− | 0.264 | 0.328 | −0.274, 0.802 |
| CD34+/CD31+/CD45+/CD133− | 0.504 | 0.259 | −0.386, 1.394 |
Notes: Log-transformed outcomes were regressed on ET-1.
significance at 0.05 < P< 0.10 level.
Abbr.: CAC: circulating angiogenic cell; ET-1: endothelin-1.